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The spontaneously hypertensive/NIH-corpulent
(SHR/N-cp) rat is a genetic animal model that ex-
hibits obesity, metabolic features of hyperinsuline-
mia, hyperglycemia, and hyperlipidemia, which are
characteristic of type II diabetes and mild hyperten-
sion. To determine the role of leptin, the protein
product of the ob gene, in the development of obe-
sity and diabetes in this model, we measured
steady-state circulating levels of leptin in obese and
lean SHR/N-cp rats and examined the relation
between plasma leptin levels and metabolic vari-
ables at the stage of established obesity in these ani-
mals. Mean fasting plasma leptin concentration was
8-fold higher in obese than in lean rats (p0.01).
This was associated with a 6-fold elevation in
plasma insulin in the obese group. Fasting levels of
plasma glucose, cholesterol, and triglyceride were
all significantly higher in obese rats than in lean
controls. Spearman correlation analysis showed a
significant positive correlation between plasma lep-
tin concentration and body weight among the ani-
mals (r=0.73, p0.01). Similarly, plasma insulin
concentration was significantly correlated with BW
in all animals (r=0.54, p0.05). There was also a
significant positive correlation between plasma lep-
tin and plasma insulin in the entire group (r =0.70,
p K0.01). However, this relationship was significant
only for lean rats but not for obese rats (r=0.59,
p K0.05 for lean rats, and r =0.23, p NS, for obese
rats). Plasma leptin also correlated positively with
fasting plasma glucose (r =0.75, p 0.05), total cho-
lesterol (r 0.63, p 0.05), and triglyceride (r 0.67,
p K0.05). The marked elevation of plasma leptin in
obese SHR/N-cp rats suggests that obesity in this
animal model is related to up-regulation of the ob
gene. Circulating leptin appears to be one of the
best biological markers of obesity and that hyper-
leptinemia is closely associated with several meta-
bolic risk factors related to insulin resistance in the
diabesity syndrome.
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INTRODUCTION
Obesity and type II diabetes or non-insulin-
dependent diabetes mellitus (NIDDM) are two
prevalent disorders that have become a major
public health concern in industrialized countries
because of their frequent association with cardio-
vascular risk factors, namely, hypertension, dys-
lipidemia, atherosclerosis, and coronary heart
disease.I1-31 These two conditions often coexist
and have in common the metabolic features of hy-
perinsulinemia and glucose intolerance. I4’ 51 In fact,
both are considered as disorders of insulin resist-
ance. I61 Since the identification of the obese (ob)
gene in 1994,I71 it became apparent that obesity in
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humans as well as in animals is associated with
abnormalities in the expression this gene and its
protein product, leptin. In the ob/ob mouse, a mu-
tation in the ob gene causes a deficiency of leptin
and leads to increased food intake, reduced en-
ergy expenditure, and marked obesity.[8-11 Ad-
ministration of leptin to these mice reduces food
intake, body weight, and adiposity.[7-1 In con-
trast to findings in ob/ob mice, ob gene expression
and circulating leptin levels are increased in obese
humans and both factors correlate positively with
the amount of body fat.In-131 Similarly, leptin
mRNA expression and circulating leptin have also
been found to be elevated in most other rodent
models of obesity, including diabetic (db/db) mice,
Wistar fatty rats, Zucker (fa/fa rats), and ventro-
medial hypothalamus-lesioned mice.[14-17]
The spontaneously hypertensive/NIH-corpu-
lent (SHR/N-cp) rat is a genetic animal mod-
el that exhibits obesity, metabolic features of
hyperinsulinmia, hyperglycemia, and hyper-
lipidemia characteristic of NIDDM, and mild
hypertension.[18-21 Unlike other rodent models
of obesity, the SHR/N-cp rat is a congenic strain.
This was achieved by an initial mating of a male
obese spontaneously hypertensive (Koletsky) rat
which was heterozygous for the cp gene with a
spontaneously hypertensive rat (SHR) of the
Okamoto strain, followed by multiple rounds
of back-crossing of the progeny to the SHR
strain. [19,2] Since the cp gene is autosomal reces-
sive and the corpulent homozygotes (cp/cp) do
not reproduce, heterozygotes (cp/+) were used
in backcrossing to produce the next generation
of animals. A minimum of ten backcrosses was
carried out to eliminate the non-cp genes of the
Koletsky strain. Once the congenic strains were
established, mating of heterozygotes yields three
genotypes but only two phenotypes: homo-
zygous (cp/cp) corpulent, heterozygous (cp/+)
lean, and homozygous (+/+) lean, in a ratio of
1:2:1. Corpulent homozygotes, unlike their lean
littermates, are characterized by central (abdom-
inal) obesity, hyperglycemia, hyperinsulinemia,
hyperlipidemia, and mild hypertension.
The role of leptin secretion and its relationship
to hyperinsulinemia in this strain has not been
examined. This is of interest since leptin has
been suggested to play a causative role in in-
sulin resistance associated with obesity.[2] Con-
sequently, we have studied the SHR/N-cp rat to
examine the effect of genetic obesity on leptin in
this model. Specifically, we determined steady-
state circulating levels of leptin in corpulent and
lean SHR/N-cp rats and examined the relation
between plasma leptin levels and metabolic pa-
rameters at the stage of established obesity in
these animals.
MATERIALS AND METHODS
Male SHR/N-cp rats were obtained from the
National Institutes of Health at 5-6 weeks of
age. At this age, obesity is already evident in
SHR/N-corpulent (cp/cp) rats as suggested by
higher body weight than their lean littermates
and increased fat in the abdomen. All proce-
dures for the study were approved by the Insti-
tutional Animal Care and Use Committees of
the George Washington University, Washington,
D.C., and Agricultural Research Service, U.S.
Department of Agriculture, Beltsville, Maryland.
All animals were housed individually in stain-
less steel wire cages with controlled temperature
(21 to 25C) and relative humidity (40 to 50%)
and maintained on a reverse 12-hour dark (0900
to 2100 hr) and light (2100 to 0900 hr) cycle. Rats
were fed a 54% carbohydrate diet containing
36% starch and 18% sucrose, plus: 10% casein,
10% lactalbumin, 6% cellulose, 8% corn oil, 4%
lard, 4% beef tallow, 3.5% salt mix, and 1% vita-
min mix. The diet (obtained from Dyets Inc.,
Bethlehem, PA) provided approximately 49%
energy from carbohydrate, 18% from protein,
and 33% from fat. Animals were maintained on
this diet for 3 months. Body weight was meas-
ured monthly in each animal throughout the
study. At the end of the feeding period, animals
were sacrificed by decapitation. Blood samples
were obtained with the animals in the fasting
state for 12h and collected in EDTA and Trasylol
for determinations of leptin, glucose, insulin,
total cholesterol, and triglycerides in the plasma.
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Analytical Measurements
Plasma glucose concentration was measured by
the hexokinase method described by Bondar
and Mead. [22] Plasma insulin was measured by
radioimmunoassay using the double antibody
procedure. Plasma cholesterol and triglyceride
concentrations were measured enzymatically in
a Centrifichem 600 system (Serono-Baker Diag-
nostics, Allentown, Pa.). Immunoreactive leptin
in plasma was determined by radioimmuno-
assay using a kit from (Linco Research Inc,
St. Charles, MO).
Statistical Analysis
Results are expressed as mean_ SEM. Compari-
sons between groups were made using one-way
analysis of variance (ANOVA). Differences be-
tween mean values in the two groups were
tested by Student’s t-test. Correlations between
leptin and the various variables were examined
by Spearman correlation analysis (SAS Insti-
tute). Differences were considered significant
when the p value was < 0.05.
RESULTS
All animals progressively gained weight on the
54% carbohydrate diet with the obese group
showing considerably higher body weight than
the lean group throughout the study. At approxi-
mately six weeks on the diet, body weight of
obese rats (n =4) averaged 427 + 12g compared
with 362_22g in lean rats (n=4) (p<0.025).
At this period, mean fasting plasma leptin con-
centration was 34.1+__1.8 xg/1 in obese rats
and 7.5 _+ 1.3 xg/1 in lean littermates (p <0.001).
Fasting plasma insulin levels were also sig-
nificantly higher in obese than in lean rats with
a mean value of 4.46_0.8nmol/1 in the
obese group compared with 0.35 _0.1nmol/ml
(p < 0.001).
At the end of 12 weeks on the diet, obese and
lean rats showed further increases in body
weight, plasma leptin, and plasma insulin
(Tab. I). The mean body weight of obese rats was
30% higher than that of their lean littermates
(p < 0.0001). Mean fasting plasma leptin concen-
tration was approximately 8-fold higher in obese
than in lean controls (p < 0.01); whereas, plasma
insulin was 6-fold higher in the obese than in the
lean group (p < 0.01). In addition, fasting levels
of glucose, cholesterol, and triglycerides were all
significantly higher in obese rats than in lean
rats.
Spearman correlations between leptin and
various parameters in all animals are summa-
rized in Table II. There was wide variability in
plasma leptin and plasma insulin levels among
the animals. Individual levels of plasma lep-
tin were positively correlated with body weight
among all rats (r=0.73, p<0.01) (Fig. 1).
Similarly, plasma insulin concentration was
TABLE Fasting plasma levels of leptin, insulin, glucose, total
cholesterol, and triglyceride in obese and lean SHR/N-cp rats
Obese Lean
Parameter (n 9) (n 12)
Body weight, g 580 9* 447 9
Plasma leptin, g/1 112 11" 13.8 +_ 3
Plasma insulin, nmol/1 7.2 2* 1.2 +__ 0.3
Plasma glucose, mmol/1 9.5 0.5* 7.5 0.3
Plasma total cholesterol, mmol/1 4.4 0.4* 2.9 0.4
Plasma triglycerides, mmol/1 11.2 3* 2.4 0.6
Values are means SE.
*P < 0.01, compared with lean.
TABLE II Spearman correlation coefficients between metabolic variables in SHR/N-cp
rats
Variables Leptin Insulin Glucose Cholesterol Triglycerides
Body weight 0.73** 0.54* 0.73* 0.71" 0.57*
Leptin 0.70** 0.75* 0.63* 0.67*
Insulin 0.66* 0.36 0.27
Number of rats 21; **p < 0.01; *p < 0.05.
INTERNATIONAL JOURNAL OF EXPERIMENTAL DIABETES RESEARCH220 M. T. VELASQUEZ et al.
200
160
120
40
0.73
p < 0.01
n=21
0 0
0
0 OO
0 00 O 0
300 400 500 600 700
Body Weight, g
FIGURE Relationship between plasma leptin concentra-
tion and body weight in SHR/N-cp rats. Open circles repre-
sent lean rats (n 12) and closed circles represent obese rats
(n 9).
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FIGURE 2 Relationship between plasma leptin and plasma
insulin in SHR/N-cp rats.
significantly correlated with body weight in all
animals (r=0.54, p<0.05). There was also a
significant positive correlation between plasma
leptin and plasma insulin in the entire group
(r =0.70, p <0.01) (Fig. 2). However, this direct
relationship was significant only for lean rats
but not for obese rats (r 0.59, p < 0.05 for lean
rats, and r 0.23, p NS, for obese rats). Plasma
leptin also correlated significantly with fasting
plasma glucose (r =0.75, p <0.05), total choles-
terol (r 0.63, p < 0.05), and triglyceride (r 0.67,
p < 0.05).
DISCUSSION
Our study is the first evaluation of plasma leptin
and its relationship to insulin and metabolic pa-
rameters in the SHR/N-cp rat, a genetic animal
model of obesity, NIDDM, and hypertension.
Our results demonstrate that plasma leptin lev-
els are consistently higher in obese SHR/N-cp
rats when compared with their lean littermates.
Further, the hyperleptinemia was observed at an
early age, e.g., approximately 12 weeks of age,
when obese rats already show higher body
weight compared with lean rats. Hyperinsuline-
mia is also observed in obese SHR/N-cp rats as
early as 4 weeks of age. [23] After 12 weeks of
feeding a high carbohydrate diet, both obese
and lean rats gained more weight and exhibited
8-fold higher fasting levels of plasma leptin than
their lean littermates. However, we noted wide
variations in plasma leptin in both lean and
obese rats, even though they were all of the
same age and gender, and on the same diet. This
interindividual variation in leptin may be due
to the genetic background of the animals. The
lean group comprised of heterozygous (cp/+)
and homozygous (+/+) lean rats, whereas, the
obese group consisted of homozygous (cp/cp)
corpulent rats. This is further suggested by a re-
cent study of Cleary et al. [24] in the Zucker fatty
rat, which showed that heterozygous (FA/fa)
lean rats had higher levels of plasma leptin
when compared with homozygous (FA/FA) lean
rats. In our study, we did not separate hetero-
zygous lean SHR/N-cp rats from homozygous
lean animals. Nevertheless, individual levels of
plasma leptin in the entire group were positively
correlated with body weight.
Our results are complementary to previous
reports showing a positive correlation between
circulating leptin and body fat mass in obese
humans as well as in several animal models of
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obesity. [12,13,16] In contrast to findings in the
ob/ob mouse which lacks the ob gene and lep-
tin,I71 the marked elevation of plasma leptin in
obese SHR/N-cp rats indicates that adiposity in
these animals, like that in most other rodent
models of obesity, is related to up-regulation of
the ob gene. Indeed, several studies have shown
that ob mRNA levels and leptin secretion are
augmented in direct proportion to severity of
obesity in diabetic (db/db) mice, Wistar fatty rat,
and Zucker (fa/fa) rats. [14-16] More relevant to
the present study is the finding by Hiraoka and
co-workersI251 of a marked increase in ob gene
expression and leptin secretion in the obese SHR
or Koletsky rat, the parent strain from which the
SHR/N-cp rat was originally derived. In their
study, plasma leptin levels were found to be 100-
fold higher in obese than in lean SHRs, whereas
in our study, serum leptin levels were about
8-fold higher in obese SHR/N-cp rats com-
pared with their lean littermates. Additionally,
Shillabeer et al. [26] reported increased mRNA
leptin levels in proportion to adipocyte number
in JCR: LA-corpulent rats, a substrain which is
also derived from obese SHR.
Obese SHR/N-cp rats also exhibited marked
hyperinsulinemia, mild hyperglycemia, hyper-
cholesterolemia, and hypertriglyceridemia, as has
been observed in previous studies. I18’ 19] We have
previously reported that the hyperinsulinemia in
obese rats is associated with marked hyperplasia
of pancreatic ]3-cells.I21 In the present study, the
marked hyperinsulinemia in obese SHR/N-cp
rats was associated with marked elevations in
fasting serum leptin concentrations, suggesting
an interaction between these two hormones in
the development of obesity. Insulin has recently
been suggested to play an important role in the
regulation of leptin secretion, in addition to its
contributory role in the development of obesity
in animals and humans. Studies in rats with in-
sulin deficiency induced by streptozotocin have
shown that plasma leptin levels and leptin
mRNA are markedly reduced and treatment
with insulin in these animals restores leptin
levels to normal. I271 Acute and chronic adminis-
tration of insulin has been shown to increase
ob mRNA expression in other experimental
animals. [21,28] Taken together, these observations
indicate that plasma leptin concentrations are
markedly reduced under conditions of insulin
deficiency and are increased by exogenous in-
sulin administration. In our study of the SHR/N-
cp rat, we also found a direct correlation between
plasma leptin and insulin levels. More interest-
ingly, this relationship was more evident in lean
than in obese rats, suggesting that the expression
of these two hormones is closely linked to their
heterozygous cp background. On the other hand,
homozygous obese SHR/N-cp rats with severe
hyperinsulinemia have also markedly elevated
levels of circulating leptin. Hence, no further
increase in plasma leptin level was observed,
perhaps, because leptin secretion in the obese
animals was already maximally stimulated.
We also observed a significant positive corre-
lation between plasma leptin concentration and
fasting levels of plasma glucose, total choles-
terol, and triglycerides. These results extend the
recent observations by Haffner et al. [29] in male
non-diabetic human subjects showing a signifi-
cant correlation of serum leptin levels with
whole-body glucose disposal rate (GDR), fasting
glucose, total triglycerides, apolipoprotein B,
and low density lipoprotein (LDL) size. Similar
correlations between serum leptin levels and
body fat content, fasting insulin, fasting glucose,
and triglycerides have been reported by Iida
et al.[3] in studies of the Otsuka-Long-Evans
Tokushima-Fatty (OLETF) rat, another rodent
model of spontaneous NIDDM. Thus, it appears
that high circulating leptin may also be associ-
ated with metabolic risk factors that are related
to insulin resistance.
In contrast to the stimulatory effects of insulin
on leptin secretion, leptin has been shown in
many studies to inhibit insulin release. [8’31’32]
This effect of leptin appears to be a direct in-
hibitory action of the hormone on leptin recep-
tors (ObRb) present in pancreatic -cells.
[31’32]
This interaction between insulin and leptin has
led to the hypothesis recently proposed by
Kieffer and HabenerI331 that there exists an
adipoinsular axis, a dual hormonal feed back
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loop involving insulin and leptin produced by
pancreatic beta cell and adipocytes, respectively.
In this schema, insulin, a well-known adi-
pogenic hormone, increases body fat mass and
stimulates the production and secretion of leptin
that acts centrally to reduce food intake and in-
crease energy expenditure. Leptin in turn sup-
presses insulin secretion by both central actions
and direct actions on pancreatic beta cells. Since
circulating levels of leptin are directly propor-
tional to body fat mass, an increase in obesity in-
creases plasma leptin, thereby reducing insulin
secretion. However, it should be noted that lep-
tin lowers plasma insulin levels in ob/ob mice
which genetically lack leptin whereas it has no
insulin-lowering effect in db/db mice with de-
fective leptin receptors,I31’321 indicating that the
leptin-insulin feedback loop is disrupted in dia-
besity syndrome in mice with hyperleptinemia.
The direct association of plasma insulin with
plasma leptin observed in SHR/N-cp rats
suggests that this hormonal feedback loop is
also disrupted in this model. Such failure of this
adipoinsular axis to suppress insulin secretion
may contribute to the development of adiposity,
chronic hyperinsulinemia, and hyperleptinemia
in this model of obesity and NIDDM.
In summary, we have shown for the first time
that circulating leptin is markedly elevated in
obese SHR/N-cp rats compared with their lean
littermates. Fasting plasma leptin concentration
was positively correlated with body weight,
suggesting that obesity in this animal model is
related to upregulation of the ob gene. Plasma
insulin was also markedly elevated in obese rats
compared with lean rats and was positively cor-
related with body weight. Furthermore, plasma
leptin was significantly correlated with plasma
insulin suggesting an interaction between these
two hormones in the development of obesity in
this model. Variations in steady-state levels of
circulating leptin and insulin in lean SHR/N-cp
rats may reflect heterozygosity of their cp
gene background. Plasma leptin levels also cor-
related directly with plasma glucose, plasma
cholesterol, and plasma triglycerides. We con-
clude that circulating leptin may be one of the
best biological markers of obesity and that hy-
perleptinemia is closely associated with several
major risk factors known to be related to insulin
resistance in the diabesity syndrome.
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